Comparison of the action of morphine with potential inhibitors on the activity of MPO and HRP by Nyssen, Pauline et al.
Comparison of the action of morphine with potential 
inhibitors on the activity of MPO and HRP  
 P. Nyssena, T. Franckb, E. Sauvagec, A. Mouithys-Mickaladb , M. Hoebeke a  
a Biomedical Spectroscopy, CESAM, Faculty of Sciences, B 5a , University of Liège  - Sart-Tilman, Liège, Belgium,   bCentre of Oxygen, Research and Development, Institute of Chemistry B 6a, University  of Liège - Sart Tilman, Liège, Belgium, c 
Center for Protein Engineering , Faculty of Sciences, B 5a , University of Liège  - Sart-Tilman, Liège, Belgium 
Introduction 
The uncontrolled release in the extracellular medium of MPO, marker of inflammation, 
along with the release of ROS, causes severe damages on biological tissues. The 
modulation of the enzyme activity might constitute an approach for the treatment of 
excessive inflammation. According to several studies, morphine, which is already known 
for its analgesic properties, seems to present an antioxidant activity. Therefore, this 
reducing molecule can potentially pretend to be an inhibitor of MPO.  
 
Aims of the study 
- Evaluate the potential reducing and anti-catalytic actions of morphine on the similar 
peroxidase activity of two enzymes : MPO and HRP, with three complementary  
techniques: EPR, SIEFED and docking 
- Compare the activity of morphine versus two polyphenols, quercetin and gallic acid, and 
ascorbic acid  
 
 
Fig.1: Chemical structure of a) morphine b) ascorbic 
acid c) quercetin d) gallic acid 
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Fig.2: Scheme of the peroxydase cycle of  a  
peroxidase  enzyme triggered by the interaction with 
its natural substrate H2O2 or with a reducing 
substrate AH2  
   
 
    EPR study 
Docking study  
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Fig.3: Action of the antioxidant 
compounds on the ABTS . +  
radical. The radical is formed by 
the oxidation of ABTS by the 
peroxidase cycle of HRP. 
The percentages of inhibition of MPO 
activity for each molecules were 
calculated versus their respective 
solvent control. Data are given as mean 
± SD (n≥ 5). ( [HRP]=3,41 10-7 M, 
[H2O2]=4,85 10
-5 M, [ABTS]=6,75 10-5 M, 
in phosphate buffer pH 7.4).  
 
Fig.4: Action of the antioxidant 
compounds on theABTS . +  
radical, after 30 minutes.  
The percentages of inhibition of MPO 
activity for each molecules were 
calculated versus their respective 
solvent control. Data are given as 
mean ± SD (n≥ 5). ( [HRP]=3,41 10-7 M, 
[H2O2]=4,85 10
-5 M, [ABTS]=6,75 10-5 
M, in phosphate buffer pH 7.4).  
 
Fig.5: Scheme illustrating the SIEFED method  
 
Fig.6: Effect of the compounds on the MPO activity  
measured by the SIEFED method. The anti-catalytic action on MPO 
is studied. The percentages of inhibition of MPO activity for each 
molecules were calculated versus their respective solvent control. Data are 
given as mean ± SD (n≥ 5).   
 
Fig.7: Effect of the compounds on the MPO activity  (SIEFED 
without  the washing step). The association of the anti-catalytic 
action and the reducing action on the peroxidase cycle of MPO is studied. 
The percentages of inhibition of MPO activity for each molecules were 
calculated versus their respective solvent control. Data are given as mean ± 
SD (n≥ 5).   
 
Gallic acid and quercetin exhibit a dose-dependent action  on the 
formation of the ABTS radical state. The association of their anti-catalytic 
and their important reducing actions, due to their number of hydroxyl 
groups and their stabilization by electronic resonance, allow them to 
increase their action with time. Morphine and ascorbic acid cause a 
reduction of the ABTS+. formation at high concentration. After 30 
minutes,  no significant effect can be observed, except at 5 10-4 M.  
Gallic acid and quercetin totally inhibit the MPO 
activity, except at the lowest concentration (10-6 M). 
The SIEFED results indicate that their action  is due to 
the ability of these two polyphenols to enter the active 
site of MPO and to establish bonds with amino acids, 
which resist to the washing step of the experiment. 
Morphine does not exhibit any significant anti-
catalytic action on MPO.  However, Fig. 7 shows that 
morphine presents a reducing action on the 
intermediates of the MPO peroxidase cycle.  The 
competition between the molecule and amplex red, as 
substrate for the cycle, prevents the oxidation of the 
latter and reduces the fluorescence signal.  As 
morphine, ascorbic acid has a less efficient action on 
the MPO activity than the two polyphenols. This 
action seems to be due to the association of both 
reducing and anti-catalytic actions, the latter allowing 
an inhibition of around 90 % of MPO activity at 10-4 M.    
Fig. 8:A solution obtained by the docking of quercetin in 
the active site of MPO: heme in blue, His 95, Gln 91, Arg 
239 in green and quercetin in pink. ( Docking program: Yasara) 
Fig. 9: A solution obtained by the docking of gallic 
acid in the active site of MPO: heme in blue, His 95, 
Gln 91, Arg 239 in green and gallic acid in pink.           
( Docking program: Yasara) 
  
Fig. 10: A solution obtained by the docking of 
morphine in the active site of MPO: heme in blue, 
His 95, Gln 91, Arg 239 in green and morphine in 
pink. ( Docking program: Yasara) 
Fig. 11: A solution obtained by the docking of ascorbic 
acid in the active site of MPO: heme in blue, His 95, 
Gln 91, Arg 239 in green and ascorbic acid in pink.      
( Docking program: Yasara) 
  
The results obtained by docking are in accordance 
with the SIEFED ones. Quercetin and gallic acid 
can easily enter the active site of MPO and 
establish bonds with three important amino acids, 
taking part in the interaction of MPO with its 
natural substrate H2O2.  The aromatic cycle of the 
molecules are positioned parallel to the heme, 
preventing the access of H2O2. 
The 3D structure of morphine doesn’t allow the molecule to enter 
the active site of MPO. The molecule does not seem to establish 
bonds with the enzyme, what would explain why all the morphine 
molecules are eliminated during the washing step of the SIEFED 
experiment. In the case of ascorbic acid, the chain attached to the 
cycle prevents the molecule to correctly enter in the active site but 
the molecule could  also be able to link to Arg 239.   
Quercetin and gallic acid, two polyphenols,  exhibit a strong inhibition of 
the MPO activity thanks to their anti-catalytic action. ,In contrast , 
morphine seems to have difficulties to enter the active site of the enzyme, 
because of its structure. However, morphine acts as reducing substrate in 
the peroxidase cycle of MPO and exhibits an important reducing action at 
high concentration,  similarly to ascorbic acid.  The instability of their 
radical’s reducing action  over time is due to the low stability by electronic 
resonance of their radical state.   
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